// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

CCN5/WISP2 Protein Stimulates Pancreatic ?-Cell Proliferation and Survival through the Activations of AKT Kinase and Specific Targets within the ?-Cells

Larson Grimm - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hereditary susceptibility to Wilms tumor 5

Streptozotocin

Metabolic X Syndrome Is an AR-CAG Tract Disorder?

Lenore Katherine Beitel - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic steatohepatitis

Glutamine

Glyphosate and Glyphosate-Based Herbicide (GBH) Differentially Alters Mitochondria Metabolism and Swimming Behaviour in Larval Zebrafish

Gaurav Kaushik - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Somatostatin Receptors Colocalization with SST, Insulin and Glucagon in Huntington?s Transgenic Mice

Michael Heer - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congestive heart failure

Somatostatin

Cardiac Fibroblast Growth Factor (FGF) 16 Increases ATP-Binding Cassette (ABC) Transporter Production and Resistance to Doxorubicin-Induced Cardiomyocyte Death

Peter A Cattini - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Cardiotoxicity

Doxorubicin

FSH Synthesis Is Normal in Gonadotrope-Specific Bmpr2 Knockout Mice

Xiang Zhou - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SMAD3 and SMAD4 Are Required for FSH Synthesis By Pituitary Gonadotrope Cells In Vivo

Ulrich Boehm - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Evolutionary Adaptation in the Mammalian GnRH Receptor May Enhance FSH Regulation By GnRH

Jerome Fortin - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Buserelin

Role of Specific Phosphorylation Sites on CRTC1 and CRTC2 in the Nuclear Localization and Nuclear Exit in Rat Pinealocytes

James McTague - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Norepinephrine bitartrate

Somatic Xq26.3 Microduplication Causing X-Linked Acrogigantism (X-LAG)

Maude Millette - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acrogigantism syndrome

hGH

An Unexpected Metamorphosis: A Rare Case of Silent Corticotroph Adenoma Transforming into Pituitary Carcinoma Causing Florid Cushin-s Disease

Teik Chye Ooi - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Neuroendocrine tumors

Temozolomide

Pituitary Gland Involvement in Granulomatosis with Polyangiitis

Walter Conca - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Wegener's granulomatosis

Oraprine

Monthly Pasireotide LAR Improves Urinary Free Cortisol (UFC) in Patients with Cushin-s Disease: Results from a Randomized, Double-Blind, Multicenter, Phase III Study

Stephan Petersenn - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hyperglycemia

Pasireotide

MiR-142-3p Regulates Both the Growth Hormone Receptor and the Prolactin Receptor in Breast Cancer Cell Lines

Cynthia Gates Goodyer - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

hGH

Effects of the Truncated Growth Hormone Receptor on GH and PRL Signaling

Cynthia Gates Goodyer - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Isolated short stature

Human growth hormone

X-Linked Acrogigantism (X-LAG): Novel Histopathological and Clinical Characterisation

Sian Jose - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acrogigantism syndrome

Somatostatin

Peptidyl-Prolyl Cis-Trans Isomerase Pin1 Regulates the Androgen Receptor N-Terminal Domain

Yusuke Imamura - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Androgen Tear

Exploring the Mutator Phenotype in Prostate Cancer

Paresa Giannopoulos - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Androgen Tear

Early Weight Loss Responders to Liraglutide 3.0 Mg Achieved Greater Weight Loss and Regression to Normoglycemia, and Reduced Development of T2D, at 3 Years Versus Early Non-Responders in the Scale Obesity and Prediabetes Trial

Frank Lyons Greenway - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dyslipidemia

Liraglutide

Serum Galanin Levels in Young Healthy Lean and Obese Non-Diabetic Men during an Oral Glucose Tolerance Test

Hector Fabio Sandoval Alzate - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

galanin

Copyright © 2026. QuantiNova All rights reserved